210 related articles for article (PubMed ID: 33479266)
1. Multi-omic analysis unveils biological pathways in peripheral immune system associated to minimal hepatic encephalopathy appearance in cirrhotic patients.
Rubio T; Felipo V; Tarazona S; Pastorelli R; Escudero-García D; Tosca J; Urios A; Conesa A; Montoliu C
Sci Rep; 2021 Jan; 11(1):1907. PubMed ID: 33479266
[TBL] [Abstract][Full Text] [Related]
2. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients.
Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Ferrandez A; Rodrigo JM; Felipo V
J Mol Med (Berl); 2007 Mar; 85(3):237-45. PubMed ID: 17216205
[TBL] [Abstract][Full Text] [Related]
3. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.
Jiménez B; Montoliu C; MacIntyre DA; Serra MA; Wassel A; Jover M; Romero-Gomez M; Rodrigo JM; Pineda-Lucena A; Felipo V
J Proteome Res; 2010 Oct; 9(10):5180-7. PubMed ID: 20690770
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.
Yadav SK; Goel A; Saraswat VA; Thomas MA; Wang E; Marincola FM; Haris M; Gupta RK
J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420
[TBL] [Abstract][Full Text] [Related]
5. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis.
Montoliu C; Cauli O; Urios A; ElMlili N; Serra MA; Giner-Duran R; González-Lopez O; Del Olmo JA; Wassel A; Rodrigo JM; Felipo V
Am J Gastroenterol; 2011 Sep; 106(9):1629-37. PubMed ID: 21483460
[TBL] [Abstract][Full Text] [Related]
6. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Urios A; Rodrigo JM; Felipo V
J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
[TBL] [Abstract][Full Text] [Related]
7. Minimal hepatic encephalopathy is associated with expansion and activation of CD
Mangas-Losada A; García-García R; Urios A; Escudero-García D; Tosca J; Giner-Durán R; Serra MA; Montoliu C; Felipo V
Sci Rep; 2017 Jul; 7(1):6683. PubMed ID: 28751644
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.
Bajaj JS; Heuman DM; Sanyal AJ; Hylemon PB; Sterling RK; Stravitz RT; Fuchs M; Ridlon JM; Daita K; Monteith P; Noble NA; White MB; Fisher A; Sikaroodi M; Rangwala H; Gillevet PM
PLoS One; 2013; 8(4):e60042. PubMed ID: 23565181
[TBL] [Abstract][Full Text] [Related]
9. Selective improvement by rifaximin of changes in the immunophenotype in patients who improve minimal hepatic encephalopathy.
Mangas-Losada A; García-García R; Leone P; Ballester MP; Cabrera-Pastor A; Urios A; Gallego JJ; Martínez-Pretel JJ; Giménez-Garzó C; Revert F; Escudero-García D; Tosca J; Ríos MP; Montón C; Durbán L; Aparicio L; Montoliu C; Felipo V
J Transl Med; 2019 Aug; 17(1):293. PubMed ID: 31462286
[TBL] [Abstract][Full Text] [Related]
10. Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy.
Gallego JJ; Fiorillo A; Casanova-Ferrer F; Urios A; Ballester MP; Durbán L; Megías J; Rubio T; Cabrera-Pastor A; Escudero-García D; Felipo V; Montoliu C
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293192
[TBL] [Abstract][Full Text] [Related]
11. Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests.
Felipo V; Urios A; Giménez-Garzó C; Cauli O; Andrés-Costa MJ; González O; Serra MA; Sánchez-González J; Aliaga R; Giner-Durán R; Belloch V; Montoliu C
World J Gastroenterol; 2014 Sep; 20(33):11815-25. PubMed ID: 25206287
[TBL] [Abstract][Full Text] [Related]
12. Cirrhotic patients with minimal hepatic encephalopathy have increased capacity to eliminate superoxide and peroxynitrite in lymphocytes, associated with cognitive impairment.
Giménez-Garzó C; Urios A; Agustí A; Mangas-Losada A; García-García R; Escudero-García D; Kosenko E; Ordoño JF; Tosca J; Giner-Durán R; Serra MA; Felipo V; Montoliu C
Free Radic Res; 2018 Jan; 52(1):118-133. PubMed ID: 29262736
[TBL] [Abstract][Full Text] [Related]
13. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy.
Felipo V; Urios A; Valero P; Sánchez M; Serra MA; Pareja I; Rodríguez F; Gimenez-Garzó C; Sanmartín J; Montoliu C
Liver Int; 2013 Nov; 33(10):1478-89. PubMed ID: 23714168
[TBL] [Abstract][Full Text] [Related]
14. Increased serum interleukin-6, not minimal hepatic encephalopathy, predicts poor sleep quality in nonalcoholic cirrhotic patients.
Tsai CF; Chu CJ; Wang YP; Liu PY; Huang YH; Lin HC; Lee FY; Lu CL
Aliment Pharmacol Ther; 2016 Oct; 44(8):836-45. PubMed ID: 27518472
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics-Based Analysis of lncRNA-mRNA Interaction Network of Mild Hepatic Encephalopathy in Cirrhosis.
Wang K; Lu Y; Zhao Z; Zhang C
Comput Math Methods Med; 2021; 2021():7777699. PubMed ID: 34938356
[TBL] [Abstract][Full Text] [Related]
16. Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy.
Felipo V; Urios A; Montesinos E; Molina I; Garcia-Torres ML; Civera M; Olmo JA; Ortega J; Martinez-Valls J; Serra MA; Cassinello N; Wassel A; Jordá E; Montoliu C
Metab Brain Dis; 2012 Mar; 27(1):51-8. PubMed ID: 22072427
[TBL] [Abstract][Full Text] [Related]
17. Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: Underlying mechanisms and therapeutic implications.
Cabrera-Pastor A; Llansola M; Montoliu C; Malaguarnera M; Balzano T; Taoro-Gonzalez L; García-García R; Mangas-Losada A; Izquierdo-Altarejos P; Arenas YM; Leone P; Felipo V
Acta Physiol (Oxf); 2019 Jun; 226(2):e13270. PubMed ID: 30830722
[TBL] [Abstract][Full Text] [Related]
18. Nutritional therapy for persistent cognitive impairment after resolution of overt hepatic encephalopathy in patients with cirrhosis: A double-blind randomized controlled trial.
Sharma BC; Maharshi S; Sachdeva S; Mahajan B; Sharma A; Bara S; Srivastava S; Kumar A; Dalal A; Sonika U
J Gastroenterol Hepatol; 2023 Nov; 38(11):1917-1925. PubMed ID: 37354045
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of minimal hepatic encephalopathy in patients with liver cirrhosis in Japan: A propensity score-matching analysis.
Hanai T; Shiraki M; Watanabe S; Imai K; Suetsugu A; Takai K; Moriwaki H; Shimizu M
J Gastroenterol Hepatol; 2019 Oct; 34(10):1809-1816. PubMed ID: 30779213
[TBL] [Abstract][Full Text] [Related]
20. Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis.
Labenz C; Nagel M; Kämper P; Engel S; Bittner S; Kaps L; Galle PR; Schattenberg JM; Wörns MA; Lüssi F
Clin Transl Gastroenterol; 2021 Oct; 12(10):e00419. PubMed ID: 34665788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
